Federal contract award
75N95021P00063
ACQUISITION OF CGMP-GRADE GS-441524 FOR THE TREATMENT OF COVID-19
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.1M |
| Current contract value | $2.1M |
| Potential contract value / ceiling | $2.1M |
| Start date | Dec 31, 2020 |
| Current end date | Dec 31, 2024 |
| Potential end date | Dec 31, 2024 |
| Latest award activity | May 13, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 13, 2026 | P00009 | $-1.1K | FY26 UDO INITIATIVE ACQUISITION OF CGMP-GRADE GS-441524 FOR THE TREATMENT OF COVID-19. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Kimberly Espinosa | Contact | kimberly.espinosa@nih.gov 3018273546 | Source | Nov 24, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.